Skip to main content

Table 2 COVID clinical symptoms and laboratory results

From: COVID-19 in adults with dementia: clinical features and risk factors of mortality—a clinical cohort study on 125 patients

Symptoms at admission Total (n = 125) Survivors (n = 97) Non-survivors (n = 28) P
Fever 72.8% (91) 71.1% (69) 78.6% (22) 0.482
Cough 49.6% (62) 51.5% (50) 42.9% (12) 0.521
Expectorations 21.6% (27) 18.6% (18) 32.1% (9) 0.190
Polypnea 51.2% (64) 42.3% (41) 82.1% (23) < 0.0001
Desaturation 50.4% (63) 43.3% (42) 75.0% (21) 0.002
Minimum saturation 90 (88–92) 90 (88–92) 90 (88–91) 0.167
Digestive symptoms 16.8% (21) 18.6% (18) 10.7% (3) 0.400
Asthenia 76.8% (96) 72.2% (70) 92.9% (26) 0.023
Myalgia 15.2% (19) 15.5% (15) 14.3% (4) 1.000
Anorexia 56.8% (71) 53.6% (52) 67.9% (19) 0.201
Headache 4.0% (5) 4.1% (4) 3.6% (1) 0.688
Confusion, delirium 82.4% (103) 81.4% (79) 85.7% (24) 0.780
Initial fall 35.2% (44) 33.0% (32) 42.9% (12) 0.373
Laboratory findings
 Haemoglobin, g/dL 12.1 (10.9–13.08) 12.2 (10.9–13.3) 11.6 (10.3–12.7) 0.152
 Lymphocytes count (mm3) 0.99 (0.73–1.29) 1.0 (0.8–1.3) 0.9 (0.6–1.2) 0.032
 Lymphopaenia, % 84.8% (106) 85.6% (83) 82.1% (23) 0.544
 White blood cell count (mm3) 5.8 (3.9–7.9) 5.4 (3.9–7.1) 6.2 (4.1–8.7) 0.070
 Platelets count (mm3) 207 (164.3–265) 210 (170–261) 202 (150–283) 0.995
 Thrombopaenia, % 16.0% (20) 13.4% (13) 25.0% (7) 0.146
 Initial C-reactive protein, mg/dL 30.85 (8.75–84.75) 25.8 (8.0–64.5) 76.0 (33.0–44.0) < 0.0001
 Initial creatinine, μmol/L 78 (64–103.8) 74.0 (63.5–94.0) 127.0 (70.0–159.0) 0.003
 Aspartate aminotransferase, U/L 36 (24–54) 35 (24–53) 46 (32–61) 0.053
 Alanine aminotransferase, U/L 18 (13–31) 17.00 (13.00–31.00) 23.50 (12.75–34.75) 0.438
 Albumin, g/L 30 (26–34) 30.8 (27–34) 28.5 (23–33) 0.088
 Troponin positivity, %# 35.5% (22) 30.4% (14) 50.0% (8) 0.032
  1. Data are presented as median (IQI), % (n). P values > 0.05 (bold) indicates significant differences between survivors and non-survivors. #Troponin was available for 62 subjects